Latest Breaking News On - Pharma corporation - Page 1 : vimarsana.com

Alfresa : Notice of the 21th Ordinary General Meeting of Shareholders

Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million

/PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on.

Innocan Pharma Corporation: Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million

HERZLIYA, Israel and CALGARY, AB, May 27, 2024 /PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company

Innocan Pharma Corporation: FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain

The regulatory approval process with the U.S. Food and Drug Administration has commenced for Innocan's LPT-CBD release technology, marking a key step in the advancement of non-opioid pain management HERZLIYA

Innocan Pharma Corporation: Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey

Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey

Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain

Innocan Pharma Seeks FDA Nod for Pain Therapy

Innocan Pharma Corporation (TSE:INNO) has released an update. Innocan Pharma Corporation has taken its first stride towards FDA approval by submitt.

Innocan Pharma Corporation: Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M

Innocan Pharma Reports Full Year 2023 Results With Revenues Up Nearly 6X To $13.7M